Cargando…

A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function

INTRODUCTION: Delayed graft function (DGF) following renal transplantation is a manifestation of acute kidney injury (AKI) leading to poor long-term outcome. Current treatments have limited effectiveness in preventing DGF. Interleukin-18 (IL18), a biomarker of AKI, induces interferon-γ expression an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wlodek, E., Kirkpatrick, R. B., Andrews, S., Noble, R., Schroyer, R., Scott, J., Watson, C. J. E., Clatworthy, M., Harrison, E. M., Wigmore, S. J., Stevenson, K., Kingsmore, D., Sheerin, N. S., Bestard, O., Stirnadel-Farrant, H. A., Abberley, L., Busz, M., DeWall, S., Birchler, M., Krull, D., Thorneloe, K. S., Weber, A., Devey, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939287/ https://www.ncbi.nlm.nih.gov/pubmed/33684160 http://dx.doi.org/10.1371/journal.pone.0247972

Ejemplares similares

Use of Renal Replacement Therapy May Influence Graft Outcomes following Liver Transplantation for Acute Liver Failure: A Propensity-Score Matched Population-Based Retrospective Cohort Study
por: Knight, Stephen R., et al.
Publicado: (2016)

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2018)

Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study
por: Liao, Karen, et al.
Publicado: (2021)

A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus
por: McKie, Elizabeth A., et al.
Publicado: (2016)

Ischemic Preconditioning in the Liver Is Independent of Regulatory T Cell Activity
por: Devey, Luke R., et al.
Publicado: (2012)

Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions—A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2019)

A molecular signature for delayed graft function
por: McGuinness, Dagmara, et al.
Publicado: (2018)

Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis
por: Thorneloe, R.J., et al.
Publicado: (2016)

Changing use of antidiabetic drugs in the UK: trends in prescribing 2000–2017
por: Wilkinson, Samantha, et al.
Publicado: (2018)

A systematic review comparing the evidence for kidney function outcomes between oral antidiabetic drugs for type 2 diabetes
por: Wilkinson, Samantha V., et al.
Publicado: (2018)

Comparative effects of sulphonylureas, dipeptidyl peptidase‐4 inhibitors and sodium‐glucose co‐transporter‐2 inhibitors added to metformin monotherapy: a propensity‐score matched cohort study in UK primary care
por: Wilkinson, Samantha, et al.
Publicado: (2020)

Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: A retrospective analysis of US health insurance claims data
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care
por: Wilkinson, Samantha, et al.
Publicado: (2018)

The challenges of assessing patients' medication beliefs: a qualitative study
por: Thorneloe, Rachael J., et al.
Publicado: (2017)

Podocyte GSK3 is an evolutionarily conserved critical regulator of kidney function
por: Hurcombe, J. A., et al.
Publicado: (2019)

GSK-3β: A Bifunctional Role in Cell Death Pathways
por: Jacobs, Keith M., et al.
Publicado: (2012)

Impact of SARS-CoV-2 infection on patients with systemic lupus erythematosus in England prior to vaccination: a retrospective observational cohort study
por: Rabe, Adrian Paul J, et al.
Publicado: (2023)

Plasma lipoprotein-associated phospholipase A(2 )activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study
por: Davidson, Julie E, et al.
Publicado: (2012)

Intentional and Unintentional Medication Non-Adherence in Psoriasis: The Role of Patients’ Medication Beliefs and Habit Strength
por: Thorneloe, Rachael J., et al.
Publicado: (2018)

Translation Approach for Dentine Regeneration Using GSK-3 Antagonists
por: Zaugg, L.K., et al.
Publicado: (2020)

Real-World Investigation of Eosinophilic-Associated Disease Overlap (REVEAL): Analysis of a US Claims Database
por: Brailean, Anamaria, et al.
Publicado: (2023)

Analysis of the role of GSK3 in the mitotic checkpoint
por: Rashid, M. S., et al.
Publicado: (2018)

Non-redundant activity of GSK-3α and GSK-3β in T cell-mediated tumor rejection
por: Steele, Lynette, et al.
Publicado: (2021)

GSK-3 is an RNA polymerase II phospho-CTD kinase
por: Nieto Moreno, Nicolás, et al.
Publicado: (2020)

Novel Reporter Alleles of GSK-3α and GSK-3β
por: Barrell, William B., et al.
Publicado: (2012)

The impact of age on changes in quality of life among breast cancer survivors treated with breast-conserving surgery and radiotherapy
por: Bantema-Joppe, E J, et al.
Publicado: (2015)

Trafficking regulator of GLUT4-1 (TRARG1) is a GSK3 substrate
por: Duan, Xiaowen, et al.
Publicado: (2022)

Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
por: McCubrey, J A, et al.
Publicado: (2014)

Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles
por: Clayton, E.L., et al.
Publicado: (2010)

Dynamic range of GSK3α not GSK3β is essential for bidirectional synaptic plasticity at hippocampal CA3-CA1 synapses
por: Shahab, Lion, et al.
Publicado: (2014)

GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation
por: Gozdz, Agata, et al.
Publicado: (2017)

GSK3 is a metabolic checkpoint regulator in B cells
por: Jellusova, Julia, et al.
Publicado: (2017)

Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis
por: Gao, Fei, et al.
Publicado: (2015)

The Manager's Guide to Employee Feedback
por: Devey, Glenn
Publicado: (2014)

Lithium and Therapeutic Targeting of GSK-3
por: Snitow, Melinda E., et al.
Publicado: (2021)

‘New to me’: changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well(®) patient materials mixed‐methods feasibility study
por: Nelson, P.A., et al.
Publicado: (2017)

Reactivation of cocaine reward memory engages the Akt/GSK3/mTOR signaling pathway and can be disrupted by GSK3 inhibition
por: Shi, Xiangdang, et al.
Publicado: (2014)

Pancreatic allograft thrombosis: Suggestion for a CT grading system and management algorithm
por: Hakeem, A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uid7t19mg72ea5datkt0flmd8f